HMMR and breast carcinoma: In order to better illustrate the role of the cholesterol pathway in breast cancer invasion and metastasis, Wang et al. found that the mevalonate pathway controlled RHAMM (receptor for hyaluronan-mediated motility) through direct transcriptional regulation by YAP in metastatic breast cancer cell lines [44].